Filing Details
Neuraxis, INC (NASDAQ:NRXS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:NRXS
Neuraxis, INC (NRXS) Files Quarterly Report for Q0
Neuraxis, INC (NASDAQ:NRXS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Neuraxis, INC (NASDAQ:NRXS) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Neuraxis, INC (NASDAQ: NRXS) filed its quarterly report (Form 10-Q) on August 11, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $6.35 with a market capitalization of $28.1 million as of the filing date.
- The 10-Q filing includes updated risk factors and changes in business conditions since the last annual report, though specific revenue figures and financial results are not disclosed in this summary.
Market Context
Neuraxis, INC's stock currently trades at $6.35 with a market capitalization of $28.1M.
The 10-Q provides Neuraxis, INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Neuraxis, INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NRXS Stock Page
Frequently Asked Questions
Where can I read NRXS's SEC filings?
Browse all filings on our NRXS SEC filings page.
What types of SEC filings does Neuraxis, INC file?
Public companies like Neuraxis, INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.